Björklund Pharma

Advancing healthcare and wellness

  • Home
  • Company
  • Pipeline
  • Publications
  • Media
  • Contact

Thymosin Beta-4: A First-in-Class Molecule for Anti-inflammatory and Regenerative Therapies

Thymosin beta-4 (Tβ4) is a highly conserved, naturally occurring water-soluble peptide present in all tissues and cell types except red blood cells. This peptide plays a critical role in tissue regeneration by binding to actin and facilitating cell migration. Tβ4 is known to … Read More

Therapeutic Areas

Björklund Pharma is an early-stage biopharmaceutical company primarily focused on the development and research of thymosin beta-4 (Tβ4), a peptide with significant … Read More

Research and Development

Björklund Pharma focuses on the development of innovative biopharmaceutical products, with a primary focus on thymosin beta-4 (Tβ4). The company prioritizes ensuring … Read More

Collaborations

Björklund Pharma is an early-stage biopharmaceutical company dedicated to addressing critical market needs through innovative research and development. Recognizing the importance of global … Read More

Company News

  • New COVID-19 Research Provides Insights on the Crucial Role of Zinc in Protein Targets of Drugs That Block SARS-CoV-2 Infection
  • A Possible New Medicine for Multiple Sclerosis?
  • Thymosin Beta 4 in Dry Eye Syndrome
  • The Role of Thymosin Beta 4 in COVID-19 Treatment

Contact Us

Björklund Pharma AS
Toften 24
8610 Mo i Rana
Norway

Phone: +47 411 11 942
Email: info(at)bjorklundpharma.com

Copyright © 2025 Björklund Pharma AS